NCT04932070View on ClinicalTrials.gov

Berberine and Polycystic Ovary Syndrome

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 5, 2020

Primary Completion Date

October 6, 2020

Study Completion Date

January 26, 2021

Conditions
Polycystic Ovary SyndromeBerberine
Interventions
DIETARY_SUPPLEMENT

Berberine

2 daily oral doses (one before lunch and one dinner) of 550 mg of berberine tablets

Trial Locations (1)

27100

Azienda di Servizi alla Persona, Pavia

All Listed Sponsors
lead

Azienda di Servizi alla Persona di Pavia

OTHER

NCT04932070 - Berberine and Polycystic Ovary Syndrome | Biotech Hunter | Biotech Hunter